Armephaco JSC

Armephaco JSC EBIT per Share

The EBIT per Share of Armephaco JSC (AMP.VN) as of Oct 19, 2026 is 1,663.16 VND. In the previous year, EBIT per Share was 851.32 VND — a change of 95.36% (higher).

EBIT per Share

1,663.16VND

YoY

95.36%

Last updated:

EBIT per Share of Armephaco JSC is 2025 1,663.16 VND. EBIT per Share of Armephaco JSC was 2024 851.32 VND. It decreases by 95.36% higher compared to the previous year.

The Armephaco JSC EBIT per Share history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

EBIT per Share
Date
EBIT per Share
Jan 1, 2018
2,592.54 VND
Jan 1, 2019
3,254.77 VND
Jan 1, 2020
2,583.46 VND
Jan 1, 2021
1,624.38 VND
Jan 1, 2022
1,236.34 VND
Jan 1, 2023
1,069.33 VND
Jan 1, 2024
851.32 VND
Jan 1, 2025
1,663.16 VND
The Armephaco JSC EBIT per Share history
YEAREBIT per ShareYoY
1,663.16VND+95.36%
851.32VND-20.39%
1,069.33VND-13.51%
1,236.34VND-23.89%
1,624.38VND-37.12%
2,583.46VND-20.63%
3,254.77VND+25.54%
2,592.54VND-26.04%
3,505.54VND+21.49%
2,885.38VND+34.38%
2,147.23VND—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Armephaco JSC Stock analysis

What does Armephaco JSC do? Armephaco JSC, listed on the Vietnamese stock market with ticker AMP.VN and ISIN VN000000AMP7, is headquartered in Hanoi, Vietnam. The company went public through an IPO on January 12, 2017. Armephaco engages in the manufacture and distribution of pharmaceutical products and medical equipment. Its product range includes glucose meters, sphygmomanometers, hospital beds, medical examination tables, and syringe destroyers. The company also produces and trades a variety of medicines, such as antibiotics, vitamins, pain relievers, antipyretics, gastrointestinal treatments, and anti-allergic medications. Armephaco operates within the pharmaceutical and medical equipment sector, though specific industry classifications are not detailed. The company's website is http://armephaco.com.vn/. As a publicly traded entity, Armephaco provides healthcare-related products and services to the Vietnamese market, focusing on both medical devices and pharmaceuticals. The company's operations are centered in Hanoi, where it manages its manufacturing and distribution activities. No additional details regarding founding year, key personnel, acquisitions, or financial figures are provided in the available information. Armephaco JSC is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Armephaco JSC stock

EBIT per Share of Armephaco JSC is 1,663.16 VND in 2025.

EBIT per Share of Armephaco JSC changed from 851.32 VND to 1,663.16 VND, representing a 95.36% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of EBIT per Share Armephaco JSC since 2006 – with annual values, charts, and detailed analysis.

EBIT per Share measures operating profit allocated to each outstanding share.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Income Statement — Armephaco JSC

RevenueGross ProfitEBITEBITDANet IncomeEPSCost of Goods SoldR&D ExpensesSG&A ExpensesOperating ExpensesInterest ExpensePretax IncomeTax ExpenseDepreciation & AmortizationRevenue per ShareEBIT per ShareDiluted EPSEBITDA per ShareOther Income/Expense

All Key Metrics — Armephaco JSC